• Out­paced in the Evolu­tionary Arms Race

    by Kevin Blake — Re­ports on an­tibi­otic re­sis­tance al­most in­vari­ably be­gin with a roll call of sev­eral very big num­bers. 4.95 mil­lion deaths per year glob­ally, cal­cu­lates the World Health Or­ga­ni­za­tion. 2.8 mil­lion in­fec­tions per year in the United States re­sult­ing in 35,000 deaths, per the US Cen­ters for Dis­ease Con­trol. 10 mil­lion deaths per year by 2050 glob­ally cost­ing $100 tril­lion to the global econ­omy, es­ti­mates the Well­come Trust...

  • Trav­el­ing E. coli

    by Roberto — Whether it is to at­tend meet­ings, carry out col­lab­o­ra­tive re­search, visit fam­ily, or sim­ply ex­plore ex­otic lo­ca­tions, sci­en­tists tend to do a lot of in­ter­na­tional travel (my­self very much in­cluded). And one thing we do not want to ex­pe­ri­ence dur­ing or af­ter such travel is any sort of in­testi­nal mal­func­tion.

  • An an­tibi­otic hon­ey­comb

    by Manuel Sánchez — Atomic force mi­cros­co­py (AFM) is one of the most pow­er­ful tools in stu­dy­ing the sur­fac­es of any ma­ter­ial. So it should come as no sur­prise that it has been used in the stu­dy of vi­ral en­vel­op­es and bio­lo­gi­cal mem­branes. One of its great ad­van­tages...

  • Evo­lu­tion-Proof­ing An­tibi­otics

    by Vil­helmi­ina Haav­isto — Since the dis­co­ve­ry of pe­ni­cil­lin and its de­vel­op­ment in­to a the­ra­peu­tic agent, an­ti­bio­tics have re­vo­lu­tion­ized me­di­cine and saved count­less lives. How­ever, the way we use these life-sav­ing me­di­cat­ions is fun­da­men­tal­ly un­sus­tain­able as pa­tho­gens ra­pid­ly evolve re­sist­ance, ren­der­ing ma­ny se­ri­ous in­fect­ions ef­fect­ive­ly un­treat­able.